- Release Date: 29/05/24 09:03
- Summary: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
- Price Sensitive: Yes
- Download Document 2.8MB
Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add COV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.19M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 37.0¢ | $10.52K | 28.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17222 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 14.39pm 30/08/2024 (20 minute delay) ? |
| COV (ASX) Chart |